CYP2C18 GWAS Links CYP2C19 to Plavix Response; Randomized-Controlled Trial, PGx Consortium to Come Premium Following the GWAS, researchers plan to conduct a prospective, randomized-controlled trial and form a pharmacogenomics consortium specifically focused on validating and discovering new gene-response variants for clopidogrel. Breaking News New Products Posted to GenomeWeb: Tempus AI, Elegen, Eurofins Viracor, Almaden Genomics, Enhanc3D People in the News at Metabolon, IDT, WorldQuant Foundry, PanGia Biotech, Syantra Genome Medical, Nest Genomics Team up to Expand Access to Genetic Services Kryptos Biotechnologies Gets $1.2M Grant From RIGHT Foundation for Rapid STI Test In Brief This Week: MDxHealth, ERS Genomics, Helix, Cerca Biotech, Shuwen Biotech, More
